“showed a trend”

At 48hpf, zebrafish injected with 576pg Mo12 (n = 46) showed a trend toward decreased body length compared to control (n = 46) fish (4.75%, p = 0.08).

However, the FMO subgroup showed a trend towards reaching an uncomfortable level sooner by selecting a marginally lower threshold than the CNT participants, U = 82.5, p <.08, but not compared to the FMG subgroup, U = 55.5, p =.15.

This difference was not so evident in the aortic root, where DKO mice showed a trend toward smaller lesions compared with ApoE KO mice [1.5 × 10 5 ± 0.1 × 10 5 μm 2 (n = 7) vs. 1.9 × 10 5 ± 0.1 × 10 5 μm 2 (n = 7); P = 0.08; Fig. 1D ].

The PARK4 cohort showed a trend towards reduced CPLX1 values at older age ( P =0.08) and a trend towards lower values in females ( P =0.08).

The increase in fullness rating between pre-dosing and post-meal time points was significantly greater when receiving a dose of insulin compared to placebo (b = 10.81, SE = 4.56, DF = 28, t = 2.37, [95% CI, 1.47-20.14] P = .025, Table 5 ); the increase in this same rating between pre-dosing and post-dosing time points showed a trend toward being greater when receiving insulin compared to placebo (b = 10.56, SE = 5.71, DF = 28, t = 1.85, [95%CI −1.14 to 22.25], P = .08).

CXCR4 higher expression by lymphocytes showed a trend in associating with the density of CD3 lymphocytes (p=0.08).

Within the sepsis group, more patients with septic shock showed a trend to die compared to those without (56 vs. 29%, p = 0.08).

Although calprotectin showed a trend ( p = 0.08), EULAR responders at 6 months did not have significantly higher values of any of the markers at baseline.

Despite the decrease of adiponectin and the increase of TNF-α in HIIT group, insulin sensitivity showed a trend for improvement ( P =0.08).

Between groups analysis at the end of 6 th month using Mann-Whitney U-test (as sample in two groups was <30) showed a trend toward lower FBS in completers as compared to dropouts (completers – mean [SD]: 165.88 (42.77); dropouts: 222.73 (89.32); U = 86.0; P = 0.08).

Patients with mutated MEN1 and DAXX/ATRX pathways showed a trend toward better survival, compared to patients with the wild-type genes (p = 0.08 and 0.12, respectively).

When we performed a subgroup analysis by age, we observed that women aged over 39 years showed a trend of lower AMH levels in the TAI group when compared to women of the same age in the control group (0.9 ng/mL vs . 1.5 ng/mL, p =0.08) ( Table 5 ).

IFN-γ-concentrations showed a trend (combination vs. mNOX-E36, p = 0.08; combination vs.

In multivariable regression analysis attempting to correct for established prognostic factors, ASCT as a time-varying covariate only showed a trend toward improvement ( P= 0.08).

Pooling data from combined PB and WP treatments showed a trend for greater change in LBM from baseline to 12 wk compared with MDP treatment (0.69 kg; 95% CI: −0.08, 1.46 kg; P = 0.08).

This correlation was not seen in donor tissue, which showed a trend for a negative correlation ( r : −0.49, P = 0.08).

Testing for neurovascular coupling showed a trend towards impaired primary vasodilation and secondary vasoconstriction (p = 0.08, p = 0.09 resp.) initially and partial recovery at the time of follow-up, indicating a relative improvement in a time-dependent fashion.

Also, patients with positive depression and/or anxiety screening at the end of Phase 2 showed a trend towards a lower likelihood of achieving target LDL-C <55 mg/dL ( n = 24, 72.7% vs. n = 112, 85.5%, p = 0.08).

The second trial also showed a trend towards an improvement in OS, even if it did not reach statistical significance (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.72 to 1.02; p=0.08). 15 Moreover, a meta-analysis of the two phase III trials showed a significant survival benefit in favor of gemcitabine plus capecitabine (HR, 0.86; 95% CI, 0.75 to 0.98; p=0.02).

Analysis of change in PM alone showed a benefit to the intervention group (three studies, N = 340, SMD = −0.33, CI: [−0.62, −0.05], p = 0.02), while analysis of change in air nicotine alone showed a trend towards a benefit to the intervention group (air nicotine change: four studies, N = 421, p = 0.08).

In overweight children, these parameters showed a trend toward statistical significance ( p = 0.080, p = 0.093, p = 0.074, and p = 0.052, respectively).

MANOVA showed a trend for a significant group effect for placebo ( F (df = 8,114); p < 0.08), which was due to increased omission errors between controls and patients under placebo ( F (df = 2,61) = 4, p < 0.02).

Exercise showed a trend toward improving knee extension strength (MD = 2.61, 95% CI: [−0.28, 5.50], p = 0.08), indicating potential improvements in daily activity function and exercise endurance ( Figure 6 ). 3.7.

The electrophysiological and clinical CR effects, observed in all six patients (reduction of LFP beta activity by 48% and of UPDRS motor scores by 58% compared with baseline), were cumulative; that is, after the third daily dose of CR neuromodulation (in the evening of day 3) UPDRS motor scores showed a significant improvement ( P = 0.03), and beta activity showed a trend toward a significant reduction ( P = 0.08) compared with the evening of the first day.

Spectrin 120 was not significantly changed in either wildtype or HIF-1α knockout after HI, but the HIF-1α knockout cortex showed a trend toward more spectrin 120 than wildtype at 24 h ( Figure 5b , p=0.08).